Skip to content

Advertisement

  • Case report
  • Open Access

Infratentorial immature teratoma of congenital origin can be associated with a 20-year survival outcome: a case report and review of literature

World Journal of Surgical Oncology201917:22

https://doi.org/10.1186/s12957-019-1564-1

  • Received: 29 October 2018
  • Accepted: 9 January 2019
  • Published:

Abstract

Background

Congenital intracranial tumors are very rare and account for less than 2% of all childhood brain tumors. Teratomas constitute about one third to one half of these, predominantly located midline in the supratentorial region. Posterior fossa location rarely occurs and, based on the cases reported in the literature, commonly has a poor prognosis.

Case presentation

A newborn female, diagnosed prenatally with hydrocephalus, is presented at birth with increasing head circumference and Parinaud’s syndrome. Magnetic resonance imaging scans demonstrated a huge posterior fossa tumor with obstructive hydrocephalus. At surgery, through a suboccipital craniotomy, complete excision was achieved of a histological-proven immature teratoma. The infant received adjuvant chemotherapy for 1 year. She had normal neurological development and remained tumor-free through her 20-year follow-up.

Conclusion

The authors report this rare case of congenital posterior fossa teratoma with long-term outcome, and the literature is reviewed.

Keywords

  • Brain neoplasms
  • Congenital
  • Parinaud’s syndrome
  • Teratoma
  • Posterior fossa

Background

Congenital intracranial tumors are a rare occurrence, accounting for only 0.5–1.5% of all childhood brain tumors [1]. The most common of these tumors are teratomas, which comprise between 28.8 and 50.0% of central nervous system tumors [2, 3]. Teratomas are considered to be a subtype of germ cell tumors, containing all types of embryonic germ cell layers (ectoderm, mesoderm, and endoderm) [4]. Commonly, they are located in the supratentorial region, and in Wakai et al.’s review of 200 cases, only one was found in the posterior fossa [5]. Thus, infratentorial teratomas are rare entities. Histopathologically, teratomas are categorized as mature or immature [6]. Immature teratomas are associated with poor prognosis, due to the malignant behavior and presentation at a young age [6].

The Authors report this rare case of a posterior fossa congenital teratoma presented with Parinaud’s syndrome with long-term survival and review the literature.

Case report

A newborn female of an uneventful pregnancy of a 40-year-old woman was delivered on 1 January 1999 via cesarean section (CS) at full term, because of previous CS. She is the sixth child of non-consanguineous Saudi Arabian parents who were originally from Gizan. During her gestational period, routine fetal ultrasonographic (US) scans at the 34th week reported mild ventriculomegaly without mention of any associated brain tumor.

At birth, her Apgar score was 8 and 10, and her weight was 3150 g. Her head circumference after birth was in the 90th percentile, and the anterior fontanel was 20 × 20 mm and soft. The initial neurological exam was normal, apart from a squint, and her parents were reassured.

At the age of 3 days, her mother brought her to a polyclinic because of poor feeding. She was reassured, and a change of milk formula was satisfactory for 1 week. Because of her recurrent vomiting and irritability, a computed tomography (CT) scan was performed, which reported a large posterior fossa tumor with obstructive hydrocephalus.

On admission at 20 days old to King Abdulaziz University Hospital in Jeddah, she presented with frequent vomiting, poor feeding, and increasing head circumference. The general physical exam revealed an irritable and emaciated baby in the second percentile of weight for her age. Head circumference was 45 cm with visibly dilated scalp veins and bulging anterior fontanel. Neurological exam demonstrated a conscious baby with spontaneous movement of her upper and lower extremities with mild spasticity. Cranial nerves exam was uneventful apart from Parinaud’s syndrome (Fig. 1). Pupillary reflex was sluggish to light and vision was normal with no papilledema detected. Routine laboratory screening tests were within normal limits. Magnetic resonance imaging (MRI) scans revealed a heterogeneous 60 × 55 × 45 mm midline tumor filling most of the posterior fossa, causing anterior displacement of the brain stem and marked obstructive hydrocephalus (Fig. 2). The tumor was iso- to hyperintense on T1-weighted images and hypointense on T2-weighted images with heterogeneous enhancement.
Fig. 1
Fig. 1

Clinical photograph of the newborn demonstrating Parinaud’s syndrome

Fig. 2
Fig. 2

Preoperative T1-weighted a sagittal, b axial, and c coronal MRI scans demonstrating a 70 × 60 × 55 mm heterogeneously enhancing posterior fossa tumor with marked brain stem compression and obstructive hydrocephalus

Through a midline suboccipital craniotomy, complete resection of the tumor was achieved. During surgery, an encapsulated solid vascular tumor occupying the fourth ventricle was encountered with diverse areas of soft and firm consistency. The baby remained stable hemodynamically throughout the surgery and received a total of 250 ccs packed RBC blood. During the operation, cerebrospinal fluid (CSF) was obtained for analysis, which was within normal limits for chemistry and cell counts. CSF cytology and tumor markers studies, human chorionic gonadotropin, and alpha-fetoprotein were negative. Histopathological examination of the specimen demonstrated a variety of tissues from all three germ layers, including immature as well as mature elements. The predominant tissue was neuroectodermal, in the form of neuroepithelial rosettes and tubules, resembling neuroblastoma. Mesodermally derived immature cartilage and primitive stroma were also seen, and endodermally derived respiratory and enteric epithelium was present in the form of cystic structures (Fig. 3). The diagnosis was consistent with immature teratoma. During the postoperative period, the baby developed pneumonia that was resolved with intravenous antibiotics, and early postoperative MRI scans confirmed complete resection. She was discharged home on the 15th postoperative day in good condition. The infant received and well tolerated adjuvant carboplatin and etoposide (CARE) chemotherapy.
Fig. 3
Fig. 3

Histopathologic photomicrographs of the specimen demonstrating a predominant mature component (a) with a differentiated mature tissue component, including cystic respiratory and enteric epithelium and cartilage (b). The immature part consisted of primitive neuroblast-like cells forming a neuroepithelial rosette embedded in a hypercellular stroma (c). (Original magnification, × 100; hematoxylin-eosin stain)

At the first year anniversary follow-up, she had a mild developmental delay with a slight improvement of Parinaud’s syndrome. Follow-up MRI scans at the fifth year of age revealed the stable size of the ventricles with no tumor recurrence (Fig. 4). The patient was followed annually and had normal cognitive and neurological development; she is a university student and her recent CT scan at the age of 20 years revealed no recurrence (Fig. 5).
Fig. 4
Fig. 4

Follow-up at 12-month T1-weighted a sagittal, b axial, and c coronal MRI scans demonstrating no tumor recurrence

Fig. 5
Fig. 5

Follow-up at 20 years of age a sagittal, b axial, and c coronal CT scan demonstrating no tumor recurrence

Discussion

Primary brain tumors form 20% of pediatric neoplasms and are the second most prevalent cancer of childhood, after leukemia [7]. Teratomas, although tumors of gonads, also arise from the central nervous system [8]. Extragonadal teratomas are congenital midline tumors, located both intracranially and extracranially, e.g., in the mediastinum and retroperitoneal area [8]. They are considered to originate from primordial germ cells that fail to migrate properly during the initial weeks of embryonic development [8].

The incidence of intracranial teratoma is 0.5% of all brain tumors and 2 to 4% of intracranial tumors in the pediatric age group [911]. This becomes statistically more significant for intracranial tumors presenting at or around birth. Congenital teratomas are the most frequent intracranial tumor of the perinatal and neonatal period and are five times more common than astrocytomas, which are next in frequency at this age [3]. That is why they are considered as the leading prenatal neoplasms, according to multiple reviews [3]. Considering tumors in the pediatric age group, male children are affected more than female children, but in neonates, females predominate [9]. Both supra- and infratentorial tumors have been reported with the majority being supratentorial, contrary to the usual pattern of brain tumors observed in the pediatric age group [12].

Common presenting symptoms and signs of such tumors include symptoms related to the outflow obstruction of cerebrospinal fluid resulting in a headache, vomiting, and papilledema (Table 1) [4, 13]. Moreover, the progressive increase in head size has also been observed in many reported cases including our current case (Table 1) [4, 1316]. Infants with teratoma present with seizures in around 20% of cases [4, 13]. Compression of the tectal plate can result in what is known as Parinaud’s syndrome, which is characterized by vertical gaze palsy, convergence palsy, and accommodation palsy [14]. The tectal plate can be compressed through several mechanisms including hydrocephalus, causing either (a) direct compression of the tectal plate of the midbrain by the distended ventricular system or (b) secondary herniation, with resultant brainstem ischemia or neuronal distortion.
Table 1

Review of reported congenial teratoma cases confined to the posterior fossa

Author (year)

Mode of delivery and Apgar score

Age at diagnosis

Signs and symptoms

Tumor size

Tumor location

Histopathology

Neurosurgical intervention

Outcome

Follow-up

Current case

C section, 8 at 1 min, 10 at 5 min

20 days

Vomiting, poor feeding, and increasing head circumference

6 × 5.5 × 4.5 cm

Posterior fossa

Immature teratoma

Total resection

Alive

20 years

Algahtani et al. (2018) [22]

SVD, NR

5 years

Headache, vomiting, and irritability

NR

Posterior fossa

Mature teratoma

Total resection

Alive

6 years

Daugherty et al. (2016) [23]

NR

15 years

Headache, imbalance, and papilledema

NR

Posterior fossa

Mature teratoma

Total resection

Alive

9 months

Ferraz et al. (2014) [24]

NR

2 months

Down’s syndrome

NR

Posterior fossa

Mature teratoma

Incomplete resection

Recurrence

2 years

Thust et al. (2014) [14]

C-section, NR

11 weeks

Crying, irritability, and macrocephaly

NR

Posterior fossa

Teratoma

Incomplete resection

Recurrence

18 months

Fukuoka et al. (2014) [15]

SVD, 9 at 1 min, 10 at 5 min

12 days

Vomiting, head circumference enlargement

NR

Posterior fossa

Immature teratoma

Total resection

Alive

3 years

Algahtani et al. (2013) [4]

SVD, NR

5 years

Headache, vomiting, and irritability

NR

Posterior fossa

Mature teratoma

Total resection

Alive

1 year

Gao et al. (2013) [13]

NR, 9

4 months

Seizures, downward gaze palsy, binocular convergence

NR

Posterior fossa

Immature teratoma

Total resection

Alive

18 months

Rios et al. (2013) [25]

C section, NR

Prenatal

Incidental finding

5.3 × 4.8 cm

Posterior fossa

Immature teratoma

Biopsy

Dead

NA

Bakhtiar et al. (2012) [16]

SVD, NR

2 months

Lethargy and progressive head enlargement

5 cm

Posterior fossa

Immature teratoma

Total resection

Recurrence

4 years

Das et al. (2007) [26]

NR, NR

2 years

Headache vomiting, imbalance, and speech disturbance

NR

Posterior fossa

Immature teratoma

Incomplete resection

Dead

NA

Desai et al. (2001) [6]

C section, NR

10 days

Rapid head enlargement, vomiting, irritability

NR

Posterior fossa

Immature teratoma

Total resection

Dead

NA

Bavbek et al. (1999) [27]

SVD, NR

5 years

Head enlargement

NR

Posterior fossa

Mature teratoma

Total resection

Alive

NR

Hayashi et al. (1984) [28]

NR

27 days

NR

NR

Posterior fossa

Immature teratoma

Total resection

Dead

NA

SVD spontaneous vaginal delivery, NR not reported, C section caesarian section, NA not applicable

Furthermore, structural compression of the tectal plate by the tumor generates abnormal forces resulting in either brainstem ischemia or neuronal distortion before the development of hydrocephalus. Abnormal development of the tectal plate nuclei can be another cause of such syndrome in this patient population. This can be illustrated in our current case: partial improvement of Parinaud’s syndrome resulted after successful decompression, and no hemorrhage or infarction within the brainstem in the postoperative MRI scans suggests that tectal plate neurons may have been incompletely developed.

In a patient with congenital cerebellar teratoma, diagnosis may be prenatal or postnatal [17]. Prenatal diagnosis has increased compared to the past due to better prenatal follow-up and excellent radiological workups [17]. Diagnosis can be suspected on routine fetal ultrasound examination [17]. It may show intrauterine hydrocephalus, enlarged biparietal diameter, or brain tumor [17]. Antenatal diagnosis is usually possible as early as the 20th week of gestation [17, 18]. In addition to hydrocephalus, other common clinical conditions at the time of presentation are polyhydramnios, followed by respiratory distress and stillbirth [12]. If fetal ultrasound is suggestive of hydrocephalus due to a tumor, MRI of the fetus must be advised for definitive localization of the size and extent of the tumor and hydrocephalus [17, 18]. Usually, head circumference is enlarged before birth, and cephalopelvic disproportion becomes an indication for caesarian section [1719]. After delivery, parents may bring the baby in with a history of progressively increasing head circumference. Other history and examination are suggestive of hydrocephalus, which at this age is usually congenital [4, 15, 16]. Magnetic resonance imaging of the brain with and without gadolinium in such patients is diagnostic for tumor [4]. It usually shows a solid and cystic mass with heterogeneous enhancement and elements of calcification [4]. There is often hydrocephalus in posterior fossa teratomas as in our case report. Tumor markers like alpha-fetoprotein and β HCG help to suspect a malignant component in teratomas preoperatively [4].

Once the diagnosis of posterior fossa tumor is confirmed, the treatment of choice is complete excision of the lesion [4]. Afterward, complete clinical, as well as radiological, follow-up is recommended.

Poor survival of infants with congenital intracranial teratoma has been shown; a large number die prenatally and the rest shortly after birth [2]. In their literature review, Wakai and his colleagues found the 1-year survival rate of infants with congenital intracranial teratoma reaching 7.2% [5]. However, there have been some reports in which infants survived for a long time, such as our current case and that of Fukuoka et al. [15]. Long-term survival can be attributed to complete resection, yet this has not been entirely proven [20]. The location and the size of the teratoma are considered as significant prognostic factors rather than the histological grade [2]. Thus, posterior fossa teratomas are associated with poor outcome. Kitahara et al. have demonstrated that the use of neoadjuvant chemotherapy CARE can decrease tumor size and vascularity, paving the way for achieving total tumor resection and resulting in lower morbidity and mortality [21]. In their report, they unsuccessfully attempted surgical resection before initiation of neoadjuvant chemotherapy and then succeeded in achieving near-total resection after completing the CARE regimen [21]. This was unlike our current case, in which adjuvant chemotherapy was used after achieving total tumor resection. The unique aspect of our case is that it is the only one reporting a patient surviving more than 20 years after undergoing complete excision of a posterior fossa immature teratoma.

Conclusion

Congenital posterior fossa teratoma is a rare tumor that presents with significant large size and massive obstructive hydrocephalus. Early surgical resection is recommended with adequate perioperative care. Regular clinical and radiological follow-up is essential to assess the child’s neurological function and watch for early recurrence. Despite insufficient data in the literature about factors that favor a good outcome for posterior teratoma, we note that complete surgical resection is a significant prognosticator.

Abbreviation

CARE: 

Carboplatin and etoposide

Declarations

Acknowledgements

This research was not supported by any professional writing services or materials.

Funding

The design and collection, analysis, interpretation of data and writing of the manuscript has not been supported by any grant or fund.

Availability of data and materials

All data generated or analyzed during this study are included in this published article.

Authors’ contributions

All authors provided intellectual contribution to this manuscript. YM and SSB wrote the manuscript analyzed and interpreted the patient data. MEK confirmed the histopathological examination results. SSB reviewed the clinical notes and edited the document. All authors read and approved the final manuscript.

Ethics approval and consent to participate

This study was approved by the Research Ethics Committee of King Abdulaziz University Hospital.

Consent for publication

All participants gave written consent for the publication of the identifying photographs.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Division of Neurological Surgery, Department of Surgery, King Abdulaziz University Hospital, P.O. Box 80215, Jeddah, 21589, Kingdom of Saudi Arabia
(2)
Department of Pathology, King Abdulaziz University Hospital, P.O. Box 9946, Jeddah, 21423, Kingdom of Saudi Arabia

References

  1. Buetow PC, Smirniotopoulos JG, Done S. Congenital brain tumors: a review of 45 cases. AJNR Am J Neuroradiol. 1990;11(4):793–9.PubMedGoogle Scholar
  2. Isaacs H Jr. Perinatal (fetal and neonatal) germ cell tumors. J Pediatr Surg. 2004;39(7):1003–13.View ArticleGoogle Scholar
  3. Raisanen JM, Davis RL. Congenital brain tumors. Pathology. 1993;2(1):103–16.PubMedGoogle Scholar
  4. Algahtani HA, Al-Rabia MW, Al-Maghrabi HQ, Kutub HY. Posterior fossa teratoma. Neurosciences. 2013;18(4):371–4.PubMedGoogle Scholar
  5. Wakai S, Arai T, Nagai M. Congenital brain tumors. Surg Neurol. 1984;21:597–609.View ArticleGoogle Scholar
  6. Desai K, Nadkarni T, Muzumdar D, Goel A. Midline posterior fossa teratoma--case report. Neurol Med Chir. 2001;41(2):94–6.View ArticleGoogle Scholar
  7. Sardinas N, Marcos R, Pestana EM, Vargas J, Chi-Ramirez D, Rojas E, Esteban EM, Zarrabeitia L. Tumors of the posterior fossa in children. Rev Neurol. 1999;28(12):1153–8.PubMedGoogle Scholar
  8. Slavin KV, Ausman JI. Tumors of the pineal region. In: Rengachary SS, Wilkins RH, editors. Principles of neurosurgery. London: Mosby; 1994. p. 29.1–29.16.Google Scholar
  9. Uken P, Sato Y, Smith W. MR findings of malignant intracranial teratomas in a neonate. Pediatr Radiol. 1986;16:504–5.View ArticleGoogle Scholar
  10. Ventureyra EC. Pineal region: surgical management of tumors and malformations. Surg Neurol. 1981;16:77–84.View ArticleGoogle Scholar
  11. Whittle IR, Simpson DA. Surgical management of neonatal intracranial teratoma. Surg Neurol. 1981;15:268–73.View ArticleGoogle Scholar
  12. Takaku A, Kodama N, Ohara H, Hori S. Brain tumor in newborn babies. Childs Brain. 1978;4(6):365–75.PubMedGoogle Scholar
  13. Gao J, Zheng Z. Immature teratoma of the posterior cranial fossa in a 4-month-old infant: a case report. Oncol Lett. 2013;6(1):19–22.View ArticleGoogle Scholar
  14. Thust SC, Nandi D, Hann G. Acting on macrocephaly in the neonatal period: an illustrative case of congenital teratoma. BMJ Case Rep. 2014;2014.Google Scholar
  15. Fukuoka K, Yanagisawa T, Suzuki T, Wakiya K, Matsutani M, Sasaki A, et al. Successful treatment of hemorrhagic congenital intracranial immature teratoma with neoadjuvant chemotherapy and surgery. J Neurosurg Pediatr. 2014;13(1):38–41.View ArticleGoogle Scholar
  16. Bakhtiar Y, Yonezawa H, Bohara M, Hanaya R, Okamoto Y, Sugiyama K, et al. Posterior fossa immature teratoma in an infant with trisomy 21: a case report and review of the literature. Surg Neurol Int. 2012;3:100.View ArticleGoogle Scholar
  17. Ferreira O. Prenatal diagnosis of intracranial tumors: a case report. Pediatr Neurosurg. 1993;19:84–8.View ArticleGoogle Scholar
  18. Hoff NR, Mackay IM. Prenatal ultrasound diagnosis of intracranial teratoma. JCU. 1980;8:247–9.PubMedGoogle Scholar
  19. Cavalheiro S, Moron AF, Hisaba W, Dastoli P, Silva NS. Fetal brain tumors. Childs Nerv Syst. 2003;19:529–36.View ArticleGoogle Scholar
  20. Robles Fradejas M, Gonzalo Garcia I, De Las Casas Quispe AC, Martin Garcia A, Garcia Higuera MI, Rodriguez Minguelez M, et al. Fetal intracranial immature teratoma: presentation of a case and a systematic review of the literature. J Matern Fetal Neonatal Med. 2017;30(10):1139–46.View ArticleGoogle Scholar
  21. Kitahara T, Tsuji Y, Shirase T, Yukawa H, Takeichi Y, Yamazoe N. Neoadjuvant chemotherapy for facilitating surgical resection of infantile massive intracranial immature teratoma. Tohoku J Exp Med. 2016;238(4):273–8.View ArticleGoogle Scholar
  22. Algahtani H, Shirah B, Abdullah A, Bazaid A. Teratoma of the nervous system: a case series. Neurocirugia (Astur). 2018;29(3):143–9.View ArticleGoogle Scholar
  23. Daugherty C, Ngo T, Drehner D, Maugans T. Mature teratoma confined to the posterior fossa. Pediatr Neurosurg. 2016;51(2):93–8.View ArticleGoogle Scholar
  24. Ferraz ST, Valera ET, Brassesco MS, Santos de Oliveira R, Carlos dos Santos A, Saggioro FP, et al. Intracranial teratoma in children: the role of chromosome 21 trisomy. Neuropathology. 2014;34(2):197–200.View ArticleGoogle Scholar
  25. Rios LT, Araujo Junior E, Nacaratto DC, Nardozza LM, Moron AF, da Gloria Martins M. Prenatal diagnosis of intracranial immature teratoma in the third trimester using 2D and 3D sonography. J Med Ultrason. 2013;40(1):57–60.View ArticleGoogle Scholar
  26. Das S, Muro K, Goldman S, Rajaram V, DiPatri AJ Jr. Medulloblastoma arising from an immature teratoma of the posterior fossa. Case Rep J Neurosurg. 2007;106(1 Suppl):61–4.Google Scholar
  27. Bavbek M, Altinors N, Caner H, Agildere M, Cinemre O, Guz T, et al. Giant posterior fossa teratoma. Childs Nerv Syst. 1999;15(6–7):359–61.View ArticleGoogle Scholar
  28. Hayashi T, Hashimoto T, Harada K, Okamoto Y, Shojima K, Honda E. A huge teratoma in the posterior fossa in a neonate. Kurume Med J. 1984;31(4):335–7.View ArticleGoogle Scholar

Copyright

© The Author(s). 2019

Advertisement